Insider Trading & Ownership - Murdock Hunter R.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Murdock Hunter R.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-06-20
Sale
2025-06-23
7:42 pm
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
13,514$101.42$1,370,64738,752
(Direct)
View
2025-06-16
Sale
2025-06-18
9:16 pm
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
22,500$101.19$2,276,850112,149
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-06-20
Exercise
2025-06-23
7:42 pm
2023-03-04
2032-03-04
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
13,514$038,752
(Direct)
View
2025-06-20
Exercise
2025-06-23
7:42 pm
N/A
N/A
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
13,514$29.9138,752
(Direct)
View
2025-06-16
Exercise
2025-06-18
9:16 pm
2023-03-04
2032-03-04
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
22,500$0112,149
(Direct)
View
2025-06-16
Exercise
2025-06-18
9:16 pm
N/A
N/A
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
22,500$29.91112,149
(Direct)
View
2025-02-21
Option Award
2025-02-25
7:56 pm
N/A
2035-02-20
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
23,296$023,296
(Direct)
View
2024-02-27
Option Award
2024-02-29
5:39 pm
N/A
2034-02-26
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
36,549$036,549
(Direct)
View
2023-03-02
Option Award
2023-03-06
6:14 pm
N/A
2033-03-01
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
46,656$046,656
(Direct)
View

Ownership
2022-06-15
4:31 pm
N/A
2031-12-13
Axsome Therapeutics Inc.AXSMMurdock Hunter R.
General Counsel
0$0142,335
(Direct)
View